CSMG Technologies

CSMG Technologies was a medical device company that specialized in the development of the Live Tissue Connect (LTC) technology, a proprietary system for sutureless tissue fusion. The LTC platform used high-frequency electrical energy to create a biological bond between tissues, aiming to replace traditional sutures, staples, and glues in various surgical applications. The company's primary focus was on improving surgical outcomes by providing fluid-tight seals and reducing procedure times. While the technology showed promise in vascular and general surgery, the company eventually ceased active operations and was delisted from public exchanges.